One of the great aspects of our community, are the wonderful people we work with. Reading the front page of the Chronicle recently, we discovered that Dr. David Seftel is not only a co-founder of Ena [...]
Three weeks after their graduation party, Delinia announced they had been acquired by Celgene for $300M upfront and up to $475M in milestones. Delinia's co-founder and CSO, Jeff Greve, began with a si [...]
February 2, 2017 Benjamin Campbell CEO, Capital Advisors Group Join us for an overview of the various options available to CFO’s for cash management, Finance Heads & Controllers and a discussion [...]
Telo Therapeutics enters into an Oncology-focused research collaboration with GSK San Francisco, CA, Feb 2, 2017 – QB3@953, the Bay Area’s premier life science incubator, today announced the collabora [...]
January 19, 2017 Tassos Nicolaou President & CEO, Delpor, Inc. Should I invest in a new venture? Launch a new clinical trial? Conduct an expensive experiment? Partner with another company? Pursue [...]
January 12, 2017 Antoine Bril Servier, Scientific Director of Research and Partnerships Agenda 11:30 – 12:00 PM Lunch 12:00 – 1:00 PM Seminar 1:15 – 4:30 PM Partnering Discussions About A [...]
January 5, 2017 Lenny Teytelman Protocols.io As scientists, we are constantly expanding the frontiers of research and knowledge. Yet, we are also constantly re-discovering knowledge that others have [...]
Servier is the second largest French pharmaceutical company with over 3,000 researchers focused on novel treatments for cardiovascular disease, oncology, diabetes, CNS, and Rheumatology. This p [...]
Enable Biosciences was awarded top place in the First Annual Diabetes Innovation Challenge held in Boston for the most innovative late-stage (pre-clinical through translational) technology for their b [...]